Relapsed or Refractory Clinical Trials in Suzhou, Jiangsu
7 recruitingSuzhou, Jiangsu, China
Showing 1–7 of 7 trials
Recruiting
Phase 1
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University9 enrolled1 locationNCT07072247
Recruiting
Not Applicable
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
Relapsed or Refractory Acute Myeloid Leukemia (AML)MDS (Myelodysplastic Syndrome)
The First Affiliated Hospital of Soochow University30 enrolled1 locationNCT07500753
Recruiting
Phase 1
U96-CAR-T-Cells For R/R B-ALL
Relapsed or Refractory B Cell Leukemia and Lymphoma
The First Affiliated Hospital of Soochow University30 enrolled1 locationNCT07511426
Recruiting
Phase 2
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tarapeutics Science Inc.18 enrolled1 locationNCT05241093
Recruiting
Not Applicable
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University40 enrolled1 locationNCT06879847
Recruiting
Phase 2
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tarapeutics Science Inc.15 enrolled1 locationNCT05241106
Recruiting
Phase 1Phase 2
Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Relapsed or Refractory Non-Hodgkin's Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd100 enrolled2 locationsNCT05768529